Grifols is a global healthcare company with more than 75 years of legacy dedicated to improving the health and well-being of people around the world. Grifols produces essential plasma-derived medicines for patients and provides hospitals and healthcare professionals with the tools, information and services they need to help them deliver expert medical care.
Grifols’ three main divisions -Bioscience, Diagnostic and Hospital- develop, produce and market innovative products and services that are available in more than 100 countries. The Grifols Bioscience Division is dedicated to the treatment of medical conditions using blood or blood components. The Diagnostics Division advances patient care with innovative diagnostic solutions that improve disease detection and management and simplify laboratory operations. Grifols Hospital Division leverages expertise in sterile manufacturing to deliver a robust product portfolio that includes cleanroom technologies, compounding robotics, software-driven IV workflow systems, and patient administration devices, as well as intravenous therapies and clinical nutrition products.
Grifols Bio Supplies Division provides pharmaceutical- and diagnostic-grade blood and plasma intermediates for the biopharma and diagnostic industries.
Grifols Engineering is a Grifols company that offers innovative, experienced, flexible and professional engineering and machinery construction services to respond to all kinds of manufacturing needs, making processes safer, more efficient and more reliable for pharmaceutical and biotech industrial processes.
Grifols is headquartered in Barcelona, Spain and has 18,300 employees in 30 countries. In 2017, sales exceeded 4,300 million euros. Grifols demonstrates its strong commitment to advancing healthcare by allocating a significant portion of its annual income to research, development and innovation.”